Peyona (previously Nymusa)

Chiesi Farmaceutici SpA,Via Palermo 26/A,IT-43100 Parma,Italy🇪🇺 European Union

EMA Page

Authorised Date: Jul 2, 2009
Approval ID: 8b7824a0279f24bc
Products: 1 listed
Opinion Adopted: N/A

Overview Summary

Peyona is a stimulant medicine used for treating apnoea of prematurity, a condition in which babies born prematurely stop breathing for longer than 20 seconds. Peyona contains the active substance caffeine citrate.

Therapeutic & Classification

Therapeutic Indication

### Therapeutic indication Treatment of primary apnoea of premature newborns.

Therapeutic Area (MeSH)

Apnea

ATC Code

N06BC01

ATC Item

caffeine

Pharmacotherapeutic Group

Psychoanaleptics

Active Substances

Active Substance (Summary)

Caffeine citrate

INN / Common Names

caffeine

Active Substance Details

Substance	CAS	Monograph
Caffeine citrate	N/A	咖啡因

Quick Info

Approval ID8b7824a0279f24bc

Product NumberN/A

StatusAuthorised

Authorised DateJul 2, 2009

Opinion AdoptedN/A

Revision #N/A

Names & Aliases

EMA Name

Peyona (previously Nymusa)

Medicine Name

Peyona (previously Nymusa)

Aliases

N/A

Regulatory Flags

Orphan medicineUnknown

Generic medicineUnknown

BiosimilarUnknown

Conditional approvalUnknown

Exceptional circumstancesUnknown

Accelerated assessmentUnknown

Additional monitoringUnknown

Advanced therapyUnknown

Source Links

EMA Source

No risk management plan link.

Back to EMA Approvals